Patient Adherence - CBI

T o r e g i s t e r , c a l l 8 0 0 - 8 1 7 - 8 6 0 1 o r v i s i t w w w . c b i n e t . c o m / p a t i e n t a d h e r e n c e 

C e l e b r a t i n g a D e c a d e o f E x c e l l e n c e 

C B I ’ s 1 0 t h A n n u a l F o r u m o n 

Patient Adherence 

Improve Product Utilization through Stakeholder Collaboration 

and Patient-Centered Initiatives 

A p r i l 2 6 - 2 7 , 2 0 1 1 • L o e w s H o t e l • P h i l a d e l p h i a , P A 

Conference 

Chairperson: 

Nancy Phelan, 

Executive 

Director, 

Customer and 

Market 

Engagement, 

Pfizer Inc 

Participate in 

a Roundtable 

Discussion 

Designed for: 

• Bio/Pharmaceutical 

Product Managers 

and Brand Directors 

• Bio/Pharmaceutical 

Marketers, 

Communication 

Planners 

and Outcomes 

Researchers 

• Pharmacies 

• Payers 

CBI and Pharmaceutical Executive magazine are pleased to announce 

the 6th Annual 

Strategic Patient Adherence (SPA) Awards 

T u e s d a y , A p r i l 2 6 , 2 0 1 1 

Attend the SPA Awards Gala Luncheon and Network with the 

Industry’s Best in Class 

For submission guidelines and information, visit www.cbinet.com/SPAAwards 

Featuring Case Studies that Examine Tested Methods to 

Engage Patients and Physicians in Adherence Practices: 

Pfizer Inc and Medco use genomic information combined with patient adherence data 

to determine appropriate therapy 

Merck & Co tailors adherence communication to patients’ specific medication beliefs 

Kaiser’s BSMART strategy improves medication adherence in patients 

with chronic conditions 

Biologics implements patient-specific education outreach and 

relationship management for cancer patients 

Additional Program Highlights: 

Discuss industry standard metrics and terminology for adherence efforts 

with thought leaders from GlaxoSmithKline, AstraZeneca and 

the University of Western Ontario 

Hear about the National Consumer League’s public awareness campaign and get an 

early glimpse at media pieces that will be used in the launch 

Learn about the power of co-pay and deductible assistance programs from the 

Patient Access Network Foundation 

Hear from HHS to gain a government perspective on addressing patient compliance 

and persistency with a focus on outcomes 

Organized by: 

Lead Media Partner: 

Outstanding Support Provided by:

December 17, 2010 

Dear Colleague, 

As we prepare for CBI’s 10th Annual Forum on Patient Adherence, we reflect 

back on what has been accomplished in patient medication adherence over 

the past decade and look ahead to what is possible over the next 10 years. 

With a refocused dedication to return on investment and a greater emphasis 

on understanding the components of that ROI for adherence campaigns, the 

industry has seen a notable shift where we now see marketing groups working 

side by side with health economics and outcomes research teams to build their 

adherence efforts. 

In its tenth year, the conference agenda reflects this shift and features a diverse 

industry perspective from organizations such as Pfizer, AstraZeneca, Daiichi 

Sankyo, Merck & Co, Novartis, GlaxoSmithKline, Aetna and also includes 

perspectives from other valued stakeholders such as Kaiser, Medco, HHS, 

the Patient Access Network Foundation and the National Consumer League. 

Key topics include: 

• Gaining insight on trends and best practices in adherence campaigns across 

stakeholder groups 

• Learning how to engage patients in their treatment to achieve increased 

adherence rates 

• Exploring the shifting role of the pharmacist 

• Learning about the Medication Adherence Ratio (MAR) and how it 

impacts adherence 

This event has a rich history of recognizing the innovative and industrious 

programs that increase adherence rates, as well as showcasing cutting edge 

strategies, studies and tools that change perspectives on adherence. As past 

recipients of The Strategic Patient Adherence (SPA) Awards for Innovation 

and Scientific Excellence, we are happy to announce that the awards will be 

back again in 2011 with an updated judging panel and four more exciting 

presentations from winning programs. 

We look forward to recognizing and celebrating the achievements of thought 

leaders, technological leaders and innovative partnerships that are continuing 

to improve adherence and outcomes in Philadelphia on April 26th! 

Sincerely yours, 




Abhijit Gadkari, BS (Pharmacy), Ph.D. 

Manager, U.S. Outcomes Research 

Merck & Co, Inc 

Elizabeth Oyekan, Pharm.D., FCSHP 

Area Pharmacy Director 

Kaiser South Bay Medical Center 

Who Should Attend: 

You will benefit from 

attending this event if you have 

responsibilities or involvement in 

the following areas: 

Biopharmaceutical Companies: 

• Adherence 

• Marketing 

• Brand Management 

• Product Management 

• Health Economics 

• Outcomes Research 

• Managed Markets 

• Managed Care 

• Medicare 

• Alliances 

• Medical Information 

• Promotions Management 

Payer Groups: 

• Adherence Solutions 

• Clinical Research 

• Pharmacy Operations 

• Pharmacy Services 

Pharmacies: 

• Pharmacy Operations 

• Pharmacy Development 

• Pharmaceutical Solutions 

This conference will also 

be of interest to consulting 

organizations, technology and 

software vendors and other third 

party vendors providing data, 

marketing, communications or 

relationship management services 

to the above audience.

M a i n c o n f e r e n c e 

Day One — Tuesday, April 26, 2011 

7:30 Continental Breakfast and Conference Registration 

8:30 Chairperson’s Opening Remarks 

Nancy Phelan, Executive Director, Customer and Market Engagement, Pfizer Inc 

Ms. Phelan has nearly twenty years of sales, managed care and marketing 

leadership experience in healthcare. She is a proven leader in pharmaceutical 

marketing with deep expertise in consumer marketing, including: segmentation, 

positioning, advertising, digital, relationship marketing, public relations, media 

and blockbuster launches, including Claritin OTC and Vytorin. Her broad 

commercial leadership experience within pharmaceuticals and co-promotions, 

includes allergy, respiratory, anti-infectives, rheumatology, depression, women’s 

health, contraception, dermatology, hematology, gastrointestinal and specialty 

neuroscience therapy areas. Ms. Phelan held several positions within marketing 

for Schering-Plough, including Senior Director, Consumer Communications 

and in that capacity was responsible for Claritin DTC, before working to 

transition it to OTC. Additionally, Ms. Phelan and her team launched Clarinex 

DTC and also helped to develop the consumer launch for Vytorin. Ms. Phelan 

and her team were among the first in pharmaceuticals to launch a healthcare 

app and use gaming to engage consumers in health. During her tenure at 

Wyeth, now Pfizer, she and her Consumer Communications and e-Marketing 

team lead the establishment of all consumer marketing training and consumer 

marketing standards and procedures across all Rx brands at Wyeth as well as 

partnering with brand teams in the development and implementation of brand 

specific consumer marketing. Currently, at Pfizer, Ms. Phelan is responsible 

for Customer and Market Engagement for Specialty Neuroscience and was 

recognized with the 2010 Pfizer Innovation Excellence Leader Award. 

8:45 Shared Learning to Improve Medication Adherence — 

Ensuring that a Rising Tide Lifts all Ships 

Adherence is important to many different roles in healthcare. 

Part 

I 

P 

A 

N 

E 

L 

While stakeholders hold different roles in the process the end 

goal is the same for everyone — improve overall public health 

by increasing adherence. In this panel discussion, industry 

thought leaders share their experiences of the best methods for 

addressing adherence — whether that is building partnerships, 

implementing new technologies or methods, etc and what they 

see as the biggest opportunities still out there for adherence 

improvement. Then break out into four strategic stakeholder 

groups to share experiences and learn best practices for how 

your stakeholder group can meet the challenges ahead for 

overcoming patient non-adherence. 

• Gain direction on trends and best practices across 

stakeholder groups 

• Take away strategies to approach your adherence 

program with a fresh perspective 

• Hear methods and data that can rejuvenate 

company-wide enthusiasm and executive support for 

adherence efforts 

Moderator: 

William H. Shrank, M.D., MSHS, Division of Pharmacoepidemiology 

and Pharmacoeconomics, Department of Medicine, 

Brigham and Women’s Hospital; Harvard Medical School 

Panelists: 

Lawrence M. Brown, Pharm.D., Ph.D., Director, UT Center for Medication 

Therapy Management, Associate Professor, University of Tennessee 

Health Science Center, College of Pharmacy 

Abir Makarem, Pharm.D., Regional OPCS Pharmacist Project Manager, 

Kaiser Permanente 

Brent Gibbs, Vice President Managed Markets, Millennium Laboratory 

Grant Corbett, Principal, Behavior Change Solutions 

William Kelly, Senior Manager, Pull Through Marketing and Strategic Services, 

Daiichi Sankyo 

Stefan Merlo, Associate Director, Exjade Marketing, Novartis Oncology 

Jeff Haresnape, Director of Consumer Relationship Building, 

GlaxoSmithKline 

Ira Klein, Medical Director National Accounts, Analyst, Sales and Support, 

Aetna 

R o u n d t a b l e D i s c u s s i o n s 

9:15 Stakeholder Roundtable Discussions 

Choose a topic below that addresses the specific challenges 

Part faced by your role incorporating adherence programs that 

II influence behavior and increase patient compliance and 

persistency. Then join your peers in a discussion to share 

experiences and discover solutions to specific obstacles. 

A 

B 

C 

D 

A Discussion for Product Managers and 

Directors on Optimizing Compliance and 

Persistence in Brand Strategy 

Facilitated by: Grant Corbett, Principal, Behavior Change Solutions 

Stefan Merlo, Associate Director, Exjade Marketing, Novartis Oncology 

Jeff Haresnape, Director of Consumer Relationship Building, GlaxoSmithKline 

A Discussion for Marketers, Planners and Industry 

Researchers on Establishing Metrics, Milestones 

and Benchmarks in Adherence Programs 

Facilitated by: Brent Gibbs, Vice President Managed Markets, 

Millennium Laboratory 

William Kelly, Senior Manager, Pull Through Marketing 

and Strategic Services, Daiichi Sankyo 

A Discussion on How Pharmacies and Pharmacists 

Can Impact Patient Adherence 

Facilitated by: Lawrence M. Brown, Pharm.D., Ph.D., Director, UT Center 

for Medication Therapy Management, Associate Professor, University of 

Tennessee Health Science Center, College of Pharmacy 

Abir Makarem, Pharm.D., Regional OPCS Pharmacist Project Manager, 

Kaiser Permanente 

A Discussion on How Payers and Providers Can 

Substantively Improve Patient Adherence and Outcomes 

Facilitated by: Ira Klein, Medical Director National Accounts, 

Analyst, Sales and Support, Aetna 

William H. Shrank, M.D., MSHS, Division of Pharmacoepidemiology 

and Pharmacoeconomics, Department of Medicine, 

Brigham and Women’s Hospital; Harvard Medical School 

Paulo Machado, CEO/Founder, Health Innovation Partners, LLC 

10:00 Roundtable Leaders’ Recap 

Reconvene as a larger group to hear panelists recap solutions 

discussed at each roundtable. 

10:30 Networking and Refreshment Break 

11:00 Engage Patients in Their Treatment to Achieve 

Increased Adherence Rates 

Kaiser Permanente’s BSMART strategy impacts adherence 

by addressing secondary non-adherence. In combination with 

Case 

Study 

tools and reports, the BSMART strategy has been piloted 

in outpatient settings to address adherence challenges in the 

Diabetes and Dislipidemia population. These tools, baseline 

metrics and strategies have now been translated into addressing 

other chronic conditions’ adherence challenges. Benefit 

from this session by learning how to engage patients in their 

treatment to achieve increased adherence rates. 

• Learn about the tools Kaiser Permanente developed 

• Establish an understanding of Kaiser’s metrics 

for success 

• Discuss the opportunities to transfer this approach to 

other therapeutic areas 

Elizabeth Oyekan, Pharm.D., FCSHP, Area Pharmacy Director, 

Kaiser South Bay Medical Center

11:30 Medication Therapy Management and the Shifting 

Role of the Pharmacist 

The goal of medication adherence should be improving 

adherence to the best drug therapy for the patient, not simply 

adherence to whatever is prescribed. Therefore, if we want 

to improve adherence for the purpose of improving health 

outcomes, we must first make sure that we use a clinically 

proven outcomes based patient centered approach to ensure all 

of a patient’s prescription and non-prescription medications 

are indicated, are compatible and the most effective and safest 

for the patient. In this session, understand the benefits of 

utilizing the Medication Therapy Management approach and 

how it is aiding in the shift of the pharmacist to more of a care 

provider role. 

• Identify and establish roles of the key players in the 

Medication Therapy Management approach 

• Hear data to support efficacy of approach 

• Discuss the program’s challenges and opportunities to 

pharmacists and pharmacies 

Lawrence M. Brown, Pharm.D., Ph.D., Director, UT Center for Medication 

Therapy Management, Associate Professor, University of Tennessee 

Health Science Center, College of Pharmacy 

12:00 sixth Annual SPA Awards Gala LUNCHEON 

Winner Presentations 

These presentations provide insight into the 

goals, objectives and accomplishments of these 

award winning patient compliance programs. 

1:15 Award Winner — Best Branded Program 

1:35 Award Winner — Scientific Pursuit of Excellence 

1:55 Award Winner — Best Managed Care Program 

2:15 Award Winner — Employee Participation Program 

2:35 Award Winner — Innovation 


3:30 Understand and Target the Behavioral Causes of 

Non-Compliance 

Non-adherence to medication and treatment plans is often 

attributed to forgetfulness or “non-compliance” on the 

patient’s part. While these are contributors, over 40 years and 

32,000 articles of adherence research have demonstrated that 

non-adherence is a much more complex issue that often is not 

intentional. In this session, learn how patient segmentation, 

behavioral profiles and subsequent tailored interventions can 

dramatically improve adherence outcomes. 

• Consider patient and provider behavioral 

determinants for non adherence in a variety of global 

disease states 

• Review the behavioral literature and firsthand 

experiences that explain non-adherence 

• Discuss best practices to utilizing mobile and web 

technology in supporting patient adherence 

Suzanne Clough, M.D., Chief Medical Officer, WellDoc 

4:00 Self-Reported vs. Actual Adherence on Medication 

It is generally accepted that patients overstate their level 

of adherence on medications. When initially asked about 

adherence, many patients report taking their medication as 

directed. When pressed, most will admit to not always being 

100% adherent. However patients cannot state with certainty 

how adherent they are; how many days out of the last four 

weeks, for example, they took their medication exactly as 

prescribed. In this session, hear a combination of in-depth 

interviews and results from a quantitative survey, married 

with patient-level longitudinal data to evaluate adherence. 

• Examine the gap between reported and actual 

adherence 

• Discuss the differences between therapy areas and 

patients in the accuracy of self-reported adherence 

• Identify the common themes behind reasons for nonadherence 

and ways to improve adherence 

Kim Tempas, Group Director, Catalina Health Resource 

4:30 Tailor Adherence Communication to Patients’ 

Specific Medication Beliefs to Maximize Adherence 

Programs’ Effectiveness 

Recent systematic reviews have demonstrated that past 

adherence interventions have had very little success in 

moving the needle on patients’ adherence to chronic 

medications. A majority of these past interventions have 

focused on reminder programs alone; if they did focus on 

patients’ beliefs, then they did so using patients’ generic 

beliefs about medications or a disease condition. Understand 

why a generic approach is flawed and learn more about work 

and data evidence which shows that individual patients hold 

different beliefs about medications to which they are adherent 

versus non-adherent. 

• Understand why a medication-specific 

communication approach is most effective 

• Discuss practical applications into 

communications strategy 

Abhijit Gadkari, Ph.D., Manager, U.S. Outcomes Research, 

Merck & Co., Inc. 

5:00 Close of Day One 

Photo by: Photolink / Getty Images 

5:00-6:00 Networking, 

Wine & Cheese Reception 

Join colleagues and friends in a relaxed setting. 

Day Two — Wednesday, April 27, 2011 

7:30 Continental Breakfast Hosted by: 

8:30 Chairperson’s Review of Day One 

Nancy Phelan, Executive Director, Customer and Market Engagement, Pfizer Inc 

8:45 Measure and Define Adherence to Effectively 

Establish Industry Standards 

Determining the impact of a campaign on patients’ behavior 

requires the measurement and coordination of multiple sets 

of data. In addition to reconciling data from one campaign, 

it is necessary to reconcile data from multiple campaigns to 

ascertain the true changes in adherence across organizations. 

In order to assure that the multiple campaigns are weighed 

equally, industry standard language must be utilized and 

understood to ensure the proper benchmarks and milestones

P 

A 

N 

E 

L 

are set and met in each program. In this session, understand 

how adherence terminology has changed and what is 

considered standard, as well as establish metrics needed to 

support ROI and measurement success. 

• Discover the tools and data available to establish 

consistent metrics 

• Hear how to implement best practices and industry 

standards discussed by the group 

• Enhance understanding of how to reach increased ROI 

Moderator: Rob Nauman, Principal, BioPharma Advisors 

Panelists: 

Femida Gwadry-Sridhar, Assistant Professor, Departments of Medicine, 

Pharmacology and Physiology, Director Health Informatics, Lawson 

Health Research Institute; Executive Managing Director Recherche en 

Sante, Lawson – Switzerland, University of Western Ontario 

Christine Divers, Ph.D., Field Economics Director, AstraZeneca 

Steven Burch, RPh, Ph.D., Director, Evidence Based Advocacy, 


Mark Connors, Co-CEO, Pleio Health Support Systems 

9:30 Patient-Specific Education Outreach and 

Relationship Management in Adherence Efforts 

for Cancer Patients 

Assisting in patients taking their medication as prescribed is 

only one part of an important equation in optimizing therapy 

to provide the best opportunity for an improved outcome. By 

creating a personalized, clinical approach to their patient 

relationship management and education strategy, Biologics 

has increased adherence to oral cancer medication, but more 

importantly they have improved the patient experience in 

receiving oral oncology medications and increased their 

understanding of the needs of the person who has cancer. 

In this session, learn about the unique client centered way 

that Biologics successfully approaches their adherence and 

communications strategy and how the program was developed. 

Case 

Study 

• Explore the partnerships that make this 

unique model successful 

• See the data that supports the effectiveness 

for this approach 

• Understand the impact on patients and practitioners 

Daniel Duffy, Executive Vice President, General Manager, Oncology 

Pharmacy Services, Biologics Inc 

10:00 Quantifying the Level of Evidence Associating 

Medication Adherence to Improved Outcomes 

Looking back at 40 years of studies, reports and papers 

shows medication adherence is indeed linked to better 

clinical, economic and utilization outcomes among patients 

with chronic disease; however, the outcomes were not 

entirely consistent across disease categories, and there was 

a paucity of evidence for certain individual disease states. 

In this session, learn about the strength of evidence as well 

as gaps in the literature addressing the relationship between 

medication adherence and outcomes across selected common 

chronic diseases. 

• Hear how to use a rating system for quantifying the 

level of evidence in adherence-outcomes studies 

• Enhance understanding of scientific evidence that 

demonstrates that medication adherence is linked to 

better outcomes 

• Identify gaps in the adherence evidence across highly 

prevalent and/or costly disease states and their impact 

on population health metric in your own programs 

Steven Burch, RPh, Ph.D., Director, Evidence Based Advocacy, 



11:00 Practical Approaches to Leveraging Mobile 

Technology in your Adherence Efforts 

The mobile device has come a long way from just being a 

phone; it is now a handheld encyclopedia, a connector and has 

transformed our business. As a tool, mobile is being presented 

as the grandiose wave of the future, but what of those futuristic 

programs can you apply today in the real world? In this session, 

learn ways to reclaim the relationship with patients through 

mobile technologies that are available to implement today. 

• Learn the 5 steps to utilizing mobile technology to 

deliver adherence value to patients 

• Understand the roles of MMA, Carriers and HIPPA in 

mobile security and compliance 

• Examine real world examples of mobile adherence 

programs 

• Implement mobile approaches upon returning to 

the office 

Chris Crichton, Vice President, Account Services, 5th Finger 

11:30 I n t e r a c t i v e S e s s i o n — 

The 2011 Adherence Challenge 

Participants are assigned to small, diverse teams of 5 members 

that develop a creative adherence solution for a patient profile 

which is then presented to the workshop group. Each team 

quickly explains its multi-channel approach to the specific 

adherence challenge in under 3 minutes and a winner is chosen 

by a panel. The objective of this session is to facilitate peer to 

peer exchange and inspire collaboration across the healthcare 

spectrum. 

The practical benefits of this session are: 

• Improved understanding of current resources in 

adherence enhancement strategies 

• Instant peer feedback on innovative approaches to 

adherence solutions 

• Benchmarking of familiar solutions to ‘best-in-class’ 

solutions developed during the session 

Moderator: Jean Lalonde, Co-CEO, Pleio Health Support Systems Inc. 

Panel Chair: Steve Basiago, Vice President Trade Relations, Walgreens 

12:45 Raising Consumer Awareness about Adherence 

Patients, caregivers, employers, healthcare practitioners, 

academia, industry and tax payers are all impacted by poor 

adherence. Still, 3-4 Americans openly admit that they do 

not take their medication as directed. In an effort to help 

improve adherence behavior, the National Consumers League 

is launching a national medication adherence campaign, 

anchored by an extensive group of campaign partners, to help 

increase public awareness and empower individuals (and their 

care teams) to improve their adherence. 

• Learn about the consumer-oriented program and how 

it aims to engage the patient on a broader scale 

• Hear about the cutting edge methods and tools utilized 

in the grassroots component of the campaign 

• Preview upcoming campaign media and messaging 

Mimi Johnson, Director Health Policy, National Consumers League 

1:15 Luncheon hosted by:

2:15 Combine Genomic Information and Patient Adherence Data 

to Inform Appropriate Therapy 

Medco Health Solutions, Inc. and Pfizer have collaborated on an HIV/ 

AIDS personalized medicine program that (1) advises physicians 

on patient adherence to all antiretroviral medications, (2) delivers 

information on applicable genomic testing and (3) provides pharmacistbased 

counseling for patients

the 6th Annual 

Strategic Patient Adherence Awards 

Held in Conjunction with: 




p r e s e n t e d by: 

The Center for Business Intelligence andPharmaceutical Executive magazine are 

pleased to announce the 6th Annual Strategic Patient Adherence Awards. The 

Awards are presented to companies that have beendeemed exceptional in their 

compliance initiatives at the 10th Annual Forum on Patient Adherence. 

Awards will be presented to the top 4 nominees in award categories: 

1. Best Integrated Program 2. Best Branded Program 

3. Scientific Excellence 4. Best Managed Care Program 

Each award category will be meticulously reviewed by our esteemed judging panel: 

Grant Corbett, Principal, Behavior Change Solutions 

Rob Nauman, Principal, BioPharma Advisors 

William Looney, Editor-in-Chief, Pharmaceutical Executive magazine 

Jeff Simmons, Senior Director, Patient Adherence Center of Excellence, Novartis Global Oncology 

Lori-Jean Manness, Manager, Patient Adherence Solutions, Merck Canada 

Elizabeth Oyekan, Pharm.D., FCSHP, Area Pharmacy Director, Kaiser South Bay Medical Center 

Steve Basiago, Vice President, Trade Relations, Walgreens Health Services 

Femida Gwadry-Sridhar, Assistant Professor Departments of Medicine, Pharmacology and 

Physiology, Director Health Informatics, Lawson Health Research Institute; Executive Managing 

Director Recherche en Sante, Lawson – Switzerland, University of Western Ontario 

Nominations must be received or post-marked by March 4, 2011 for consideration. 

Do not miss the opportunity to celebrate your adherence successes. For more information 

regarding the awards and submission guidelines, please email: awards@cbinet.com or go 

to the awards website at www.cbinet.com/spaawards.

I n R e c o g n i t i o n o f O u r S p o n s o r s : 

CBI’s corporate sponsors represent select companies that share a common mission: business 

advancement through thought leadership, strategic interaction and innovation. The companies 

represented below are proud contributors on this program and have carefully selected 

messaging, branding or positioning statements to encourage the evaluation and investigation of 

quality products and/or services available. We applaud these companies, as well as others that 

wish to join the conference, as important members of this event’s delegation. 

If you are interested in sponsorship or exhibit opportunities, please call Lauren Moras at 339.298.2172 , 

fax 781.939.2694 or email lauren.moras@cbinet.com

T o r e g i s t e r , c a l l 8 0 0 - 8 1 7 - 8 6 0 1 o r v i s i t 

w w w . c b i n e t . c o m / p a t i e n t a d h e r e n c e 




Improve Product Utilization through Stakeholder 

Collaboration and Patient-Centered Initiatives 

April 26-27, 2011 • Loews Hotel • Philadelphia, PA 

Attend the 10th 

Anniversary event and: 

• Understand why a medication specific 

communications approach is most effective 

• Discover the tools and methods available 

to establish consistent metrics for 

adherence programs 

• Evaluate the different ways to engage 

patients in their adherence practice 

• Learn how implementing personalized 

medicine can increase adherence and outcomes 

Plus! Don’t Miss CBI and Pharmaceutical 

Executive’s 6th Annual Strategic 

Patient Adherence (SPA) Awards 

The Next Best Thing to Being There… 

Order the Online Compendium if you would like to capture what you’ve missed 

at the conference. It couldn’t be easier. The link to the online compendium is 

available for only $198 and includes the conference agenda, presentations and 

speakers’ biographies. Don’t miss out on this valuable information presented 

by industry leaders exclusively at this event. Simply fill out the order form 

and submit via phone, fax or website and you’ll receive the link to the 

Online Compendium within 2 weeks after the conference. 

• Registration Fee: Standard Advantage Pricing 

2-Day Conference $2,095 $1,795 

Advantage Pricing — Register by February 18, 2011 and SAVE $300. 

Fee includes continental breakfast, lunch, wine and cheese reception, refreshments 

and Online Compendium. Please make checks (in U.S. funds drawn on a U.S. bank) 

payable to CBI Research, Inc. (No personal checks accepted) Advantage Pricing may 

not be combined with other discount offers, special category rates or promotions. 

Discounts only apply to standard rates. 

• Team Discount: 

Your organization may send 1 executive free for every 3 delegates registered. 

All registrations must be made at the same time to qualify. 

• Accommodations: 

To receive CBI’s special discounted hotel rate on line or by phone, please go to: 

• On-line: www.cbinet.com/patientadherence 

• Phone reservations: 888.575.6397 and mention CBI’s 10th Annual 

Patient Adherence Conference 

Cut -off date is Monday, April 11, 2011. Reservations made after the cut-off date 

or after group room block has been filled (whichever comes first) will be accepted on 

a space and rate availability basis. Rooms are limited so please book early. All travel 

arrangements subject to availability. 

• Venue: 

Loews Hotel Philadelphia 

1200 Market Street • Philadelphia, PA 19107 

Phone reservations: 888.575.6397 

• Substitution & Cancellation: 

Your registration may be transferred to a member of your organization up to 24 hours 

in advance of the conference. Cancellations received in writing on or before 14 days 

prior to the start date of the event will be refunded, less a $195 administrative charge. 

No refunds will be made after this date; however, the registration fee less the $195 

administrative charge can be credited to another CBI conference if you register within 

30 days from the date of this conference to an alternative CBI conference scheduled 

within the next six months. In case of conference cancellation, CBI’s liability is limited to 

refund of the conference registration fee only. CBI reserves the right to alter this program 

without prior notice. Please Note: Speakers and agenda are subject to change. In the 

event of a speaker cancellation, every effort to find a suitable replacement will be made 

without notice. The opinions of the conference faculty do not necessarily reflect those of 

the companies they represent or The Center for Business Intelligence. 

• Satisfaction Guaranteed: 

CBI stands behind the quality of its conferences. If you are not satisfied with the 

quality of the conference, a credit will be awarded towards a comparable 

CBI conference of your choice. Please contact 800-817-8601 for further information. 

Advanced preparation for CBI conferences is not required. 

CBI 

600 Unicorn Park Drive • Woburn, MA 01801 

Registration Card DO NOT REMOVE MAILING LABEL. PLEASE RETURN ENTIRE FORM. 

Yes! Please register me for 10th Annual Patient Adherence. 

On Day One I would like to attend (select one) Roundatable A Roundatable B Roundatable C Roundatable D 

I am registering for ADVANTAGE PRICING 

I cannot attend. Please send me a Conference CD-Rom Compendium. 

We would like to take advantage of the team discount (see left for details). 

Do you have any special needs?________________________________________________ 

KEY CODE (appears above mailing address): _ ___________________________________ 

1. NAME POSITION 




COMPANY 

Address 

DIVISION 

CitY State/COUNTRY Zip/POSTAL CODE 

TELEPHONE FAx E-mail 

Authorized signature 

PRSRT STD 

U.S. Postage 

PAID 

Gallery 

PC11116 

Register 3 

Get 1 FREE 

Free 

Payment Options: Payment in full is required to process registration. Please call with any payment questions. 

Enclosed is a check for payment in full (No personal checks accepted) 

MC/Visa: 

Amex: 

Name (as appears on card) 

Cardholder signature 

ANY QUESTIONS OR TO REGISTER 

CALL Heather Munnell 

Tel: 339-298-2141 • Fax: 781-939-2459 

Email: heather.munnell@cbinet.com 

Exp. Date 

Please 

photocopy 

this form for 

additional 

delegates. 

5 Easy Ways 

to Register 

WEBSITE 

www.cbinet.com/ 

patientadherence 

Phone 

800-817-8601 

339-298-2100 

outside the U.S. 

FAX 

781-939-2490 

E-Mail 

cbireg@cbinet.com 

Please include all information 

requested on registration card. 

Mail 

CBI Registration Dept. 

600 Unicorn Park Drive 

Woburn, MA 01801

Patient Adherence - CBI

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?